Clinical Trials for Myeloproliferative Neoplasm

Find clinical trials for myeloproliferative neoplasm. Discover research opportunities and treatment options in your area.

52 Active Trials Found

Showing 52 trials on this page

Page 2 of 3

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

NCT ID: NCT06059391

This clinical trial is studying a new vaccine called the CMV-MVA Triplex vaccine, which is given to donors of stem cells to help protect patients from a common virus called cytomegalovirus (CMV) af...

Recruiting

Phase: PHASE2 Type: interventional Locations: Duarte, California, United States, Atlanta, Georgia, United States +1 more

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

NCT ID: NCT03970096

This clinical trial is looking at ways to reduce a condition called graft versus host disease (GVHD) in patients with certain types of blood cancers, such as acute leukemia or myelodysplastic syndr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tampa, Florida, United States, Pittsburgh, Pennsylvania, United States +1 more

An Optimal Dose Finding Study of N-Acetylcysteine in Patients with Myeloproliferative Neoplasms

NCT ID: NCT05123365

This clinical trial is testing the best dose of a medication called N-acetylcysteine (N-AC) for patients with certain blood disorders known as myeloproliferative neoplasms (MPN). These disorders in...

Recruiting

Phase: PHASE1 Type: interventional Locations: Orange, California, United States, Irvine, California, United States

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

NCT ID: NCT05745285

This clinical trial is studying how the services and programs offered by the Leukemia and Lymphoma Society (LLS) affect patients with blood cancers like leukemia, lymphoma, and myeloma. The goal is...

Recruiting

Phase: NA Type: interventional Locations: Chicago, Illinois, United States, Miami, Florida, United States +1 more

Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms

NCT ID: NCT05850273

**Clinical Trial Summary: Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms** This clinical trial is studying how a treatment called Peg-IFNα2a (a type of interfer...

Recruiting

Type: observational Locations: Villejuif, Ile De France, France

Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms

NCT ID: NCT06034470

This clinical trial is studying a new treatment approach for adults with newly diagnosed acute myeloid leukemia (AML) and other serious blood disorders. The treatment combines a specific chemothera...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

Evaluation of the Pathobiology of CALR-mutated MPN Cells

NCT ID: NCT06480591

This clinical trial is investigating why patients with a specific genetic mutation called CALR have a different risk for blood clots compared to those with another mutation known as JAK2. Myeloprol...

Recruiting

Type: observational Locations: Winston Salem, North Carolina, United States, Charlotte, North Carolina, United States

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

NCT ID: NCT06013423

This clinical trial is investigating a new treatment approach for patients with serious blood cancers, like acute leukemia and certain lymphomas. The study is testing how effective a transplant usi...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK)

NCT ID: NCT05839717

The CLOJAK trial is studying a type of blood disorder called Myeloproliferative Neoplasm (MPN), which can lead to blood clots. Researchers want to understand how different levels of a specific gene...

Recruiting

Type: observational Locations: Angers, , France, Bayonne, , France +9 more

Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)

NCT ID: NCT06715267

This clinical trial, called the VYP study, is focused on understanding myeloproliferative neoplasia (MPN) in children, adolescents, and young adults under 30 years old. MPN is a group of conditions...

Recruiting

Type: observational Locations: Brest, , France

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

NCT ID: NCT06138587

This clinical trial is looking at a new treatment method called preemptive CIML NK cell therapy, designed to help prevent the return of certain types of blood cancers, including acute myeloid leuke...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera

NCT ID: NCT06290765

This clinical trial is studying a medication called ropeginterferon alfa-2b to see how effective and safe it is for people with a condition known as polycythemia vera (PV), a blood disorder where t...

Not yet recruiting

Phase: PHASE4 Type: interventional

Prevalence and Risk Factors of Pulmonary Hypertension in Patients with Myeloproliferative Neoplasms in Assiut University Hospital.

NCT ID: NCT06647706

This clinical trial is focused on understanding how common pulmonary hypertension (PH)—a condition that affects blood pressure in the lungs—is among patients with myeloproliferative neoplasms (MPNs...

Not yet recruiting

Type: observational

P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk

NCT ID: NCT06468033

This clinical trial is examining the effects of a medication called Ropeginterferon alfa-2b (P1101) on adults with Primary Myelofibrosis (PMF), a type of blood cancer that can disrupt how blood cel...

Not yet recruiting

Phase: PHASE3 Type: interventional

Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

NCT ID: NCT06532084

This clinical trial is looking at a medication called sorafenib to see if it can help prevent the return of certain serious blood cancers, like acute myeloid leukemia and myelodysplastic syndromes,...

Recruiting

Phase: PHASE2 Type: interventional Locations: Saint Petersburg, , Russian Federation

BeFluBu vs FluBuRux Conditioning in Haploidentical HCT

NCT ID: NCT06477549

This clinical trial, called BeFluBu vs FluBuRux Conditioning, is studying two different treatment approaches for patients with certain types of blood cancers, such as acute lymphoblastic leukemia a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Saint Petersburg, , Russian Federation

Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)

NCT ID: NCT06462664

The clinical trial titled "Exploring the Impact of Monocytes in Myeloproliferative Neoplasia" (EMYNEM) is investigating how certain immune cells called monocytes affect the growth and development o...

Recruiting

Type: observational Locations: Brest, , France

A Prospective Patient Reported Outcomes and Wearables Study in Myeloproliferative Neoplasms

NCT ID: NCT06334913

This clinical trial is looking at how a smartphone app can help track the health and experiences of people with myeloproliferative neoplasms, which are a group of diseases that affect blood cells. ...

Not yet recruiting

Type: observational

Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

NCT ID: NCT04902833

The clinical trial titled "Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms" is investigating a specific type of blood condition known as pyruvate kinase deficiency, which can lead t...

Recruiting

Type: observational Locations: Boston, Massachusetts, United States

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT ID: NCT03452774

The SYNERGY-AI trial is exploring how artificial intelligence (AI) can help match cancer patients with the most suitable clinical trials. This study focuses on patients with various types of advanc...

Recruiting

Type: observational Locations: New York, New York, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions